Legal Representation
Attorney
Marcia A. Auberger
USPTO Deadlines
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 2, 2013 | MAB3 | O | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | Loading... |
| Jul 27, 2013 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| Jul 27, 2013 | ABN3 | O | ABANDONMENT - AFTER EX PARTE APPEAL | Loading... |
| May 13, 2013 | EXPA | T | EX PARTE APPEAL-REFUSAL AFFIRMED | Loading... |
| Dec 17, 2012 | CNES | R | EXAMINERS STATEMENT - COMPLETED | Loading... |
| Dec 17, 2012 | GNES | O | EXAMINERS STATEMENT E-MAILED | Loading... |
| Dec 17, 2012 | GNSN | O | NOTIFICATION OF EXAMINERS STATEMENT E-MAILED | Loading... |
| Nov 1, 2012 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Nov 1, 2012 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Nov 1, 2012 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| May 1, 2012 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| May 1, 2012 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| May 1, 2012 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Mar 27, 2012 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 27, 2012 | ACEC | I | AMENDMENT FROM APPLICANT ENTERED | Loading... |
| Mar 21, 2012 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Mar 6, 2012 | I | PAPER RECEIVED | Loading... | |
| Sep 13, 2011 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 13, 2011 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 13, 2011 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 8, 2011 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 14, 2011 | MPMK | O | NOTICE OF PSEUDO MARK MAILED | Loading... |
| Jul 13, 2011 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 12, 2011 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
A house mark for a full line of pharmaceutical preparations including preparations for the treatment of fever, pain, cough, allergies, and congestion
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
NON SPILL
Classification
International Classes
005